25 Jan Section 21 Access to Unregistered Medicines – IVERMECTIN CONTROLLED COMPASSIONATE USE PROGRAMME
Posted at 13:18h in
Given that there is currently no credible evidence to support a therapeutic role for Ivermectin in COVID-19, SAHPRA has decided to terminate the Programme with immediate effect.
ArchiveIvermectin Controlled Compassionate Use Programme
Download latest version
Date Updated: 19/05/2022
File Type: www
Category: Communication to industry, Guideline